Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-06-26　·　250 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 10,129.3 Mn
2033 年預估規模: USD 18,291.2 Mn
年複合成長率 CAGR: 8.8%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-06-26頁數 250報告編號 CMI9693

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Antibody Type (Murine Antibodies, Rabbit Antibodies, Chimeric Antibodies, Humanized Antibodies, Fully Human Antibodies, Recombinant Antibodies, and Others), By Usage Techniques (Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescent Immunoassay (CLIA), Western Blot (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunofluorescence (IF), Lateral Flow Assay, and Others), By Application (Cancer, Obstetrics, Dengue, Chikungunya, Helicobacter pylori, Syphilis, HIV (Human immunodeficiency virus), and Others), By End User (Clinical and Diagnostic Laboratories, Hospitals, Biopharmaceutical Companies, Research Institutions, and Others), By Distribution Channel (Offline and Online), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

報告摘要

The global monoclonal antibodies for cancer and non-cancer diagnostics market is estimated to be valued at USD 10,129.3 Mn in 2026 and is expected to reach USD 18,291.2 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2026 to 2033. The global monoclonal antibodies for cancer and non-cancer diagnostics market includes a diverse range of diagnostic products that are based on monoclonal antibodies. These antibody-based diagnostics are used to detect, distinguish, and manage a variety of diseases across different clinical indications, including oncology, infectious diseases, autoimmune diseases, and cardiovascular diseases. Due to their high levels of specificity and sensitivity, monoclonal antibodies find widespread use in several high-throughput techniques such as immunohistochemistry (IHC), enzyme-linked immunosorbent assay (ELISA), flow cytometry, and companion diagnostics. An increasing incidence of cancer, rising requirement for companion diagnostics and advancements in pathology and molecular diagnostic platforms are the key factors pushing the market’s expansion. The expansion of monoclonal antibody applications in infectious disease diagnostics, the management of autoimmune disease and personalized therapy selection will continue to fuel adoption and cement monoclonal antibodies' status as crucial tools in the diagnostic arsenal across hospitals, diagnostic labs, and research organizations. Market Dynamics The global monoclonal antibodies for cancer and non-cancer diagnostics market is driven by the increasing number of chronic diseases that need prompt and effective diagnosis, such as cancer, autoimmune disorders, and infectious diseases. Furthermore, the expanding application of precision medicine coupled with a rising demand for companion diagnostics to guide patient treatments for personalized medicines will aid market expansion. Monoclonal antibodies are widely adopted in various diagnostic methods like ELISA, IHC, flow cytometry, and biomarker testing, resulting in augmented use and thus driving the market growth. However, a number of constraints are present in the market, such as cost-intensive development and validation processes, as well as the need for thorough regulatory approvals. Nevertheless, robust demand for an earlier detection of the disease coupled with increased spending on cancer diagnostics, a growth in the use of multiplex biomarker tests for the precise diagnostics of the disease, and the increased uptake of companion tests are expected to provide lucrative opportunities for the market participants. Key Features of the Study • This report provides in-depth analysis of the global monoclonal antibodies for cancer and non-cancer diagnostics market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global monoclonal antibodies for cancer and non-cancer diagnostics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories, QIAGEN N.V., Merck KGaA, Abcam plc, and Sino Biological, Inc. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global monoclonal antibodies for cancer and non-cancer diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global monoclonal antibodies for cancer and non-cancer diagnostics market Market Segmentation • Antibody Type Insights (Revenue, USD Mn, 2021 - 2033) o Murine Antibodies o Rabbit Antibodies o Chimeric Antibodies o Humanized Antibodies o Fully Human Antibodies o Recombinant Antibodies o Others • Usage Techniques Insights (Revenue, USD Mn, 2021 - 2033) o Enzyme-Linked Immunosorbent Assay (ELISA) o Chemiluminescent Immunoassay (CLIA) o Western Blot (WB) o Immunohistochemistry (IHC) o Immunoprecipitation (IP) o Immunofluorescence (IF) o Lateral Flow Assay o Others • Application Insights (Revenue, USD Mn, 2021 - 2033) o Cancer o Obstetrics o Dengue o Chikungunya o Helicobacter pylori o Syphilis o HIV (Human immunodeficiency virus) o Others • End User Insights (Revenue, USD Mn, 2021 - 2033) o Clinical and Diagnostic Laboratories o Hospitals o Biopharmaceutical Companies o Research Institutions o Others • Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033) o Offline o Online • Regional Insights (Revenue, USD Mn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o F. Hoffmann-La Roche Ltd. o Agilent Technologies, Inc. o Danaher Corporation o Thermo Fisher Scientific Inc. o Bio-Rad Laboratories, Inc. o Abbott Laboratories o QIAGEN N.V. o Merck KGaA o Abcam plc o Sino Biological, Inc.

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Antibody Type  Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Usage Techniques  Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Application  Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By End User  Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Distribution Channel  Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Industry Trends 4. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Antibody Type, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Murine Antibodies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Rabbit Antibodies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Chimeric Antibodies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Humanized Antibodies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Fully Human Antibodies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Recombinant Antibodies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 5. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Usage Techniques, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Enzyme-Linked Immunosorbent Assay (ELISA)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Chemiluminescent Immunoassay (CLIA)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Western Blot (WB)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Immunohistochemistry (IHC)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Immunoprecipitation (IP)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Immunofluorescence (IF)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Lateral Flow Assay  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 6. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Application, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Cancer  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Obstetrics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Dengue  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Chikungunya  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Helicobacter pylori  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Syphilis  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o HIV (Human immunodeficiency virus)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 7. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By End User, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Clinical and Diagnostic Laboratories  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Hospitals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Biopharmaceutical Companies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Research Institutions  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 8. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Distribution Channel, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Offline  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Online  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 9. Global Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market, By Region, 2021 - 2033, Value (USD Mn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Antibody Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Usage Techniques, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn) o South Africa o North Africa o Central Africa 10. Competitive Landscape o F. Hoffmann-La Roche Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Agilent Technologies, Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Danaher Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Thermo Fisher Scientific Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Bio-Rad Laboratories, Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Abbott Laboratories  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o QIAGEN N.V.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Merck KGaA  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Abcam plc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Sino Biological, Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 11. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 12. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on ‘Monoclonal Antibodies for Cancer and Non-Cancer Diagnostics Market' - Global forecast to 2033

提及公司

F. Hoffmann-La Roche Ltd.Agilent Technologies, Inc.Danaher CorporationThermo Fisher Scientific Inc.Bio-Rad Laboratories, Inc.Abbott LaboratoriesQIAGEN N.V.Merck KGaAAbcam plcSino Biological, Inc.

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們